Study S003321

A PHASE 1, OPEN-LABEL, MULTIPLE DOSE STUDY TO INVESTIGATE THE IMPACT OF PF 08653944 ON GASTRIC EMPTYING IN ADULT PARTICIPANTS WITH OVERWEIGHT OR OBESITY

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07508241
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 22
Start: 2026-03-31
Primary completion: 2027-01-27
Lead sponsor: Pfizer
Conditions: Obesity; Overweight and/or Obesity; Overweight; Drug Interaction
Interventions: DRUG:PF-08653944; DRUG:Acetaminophen
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:MET097-25-106

Registered primary outcomes

Acetaminophen Pharmacokinetic (PK) Parameters: Maximum observed plasma concentration (Cmax) [Day 1 pre-dose through approximately 11 Weeks after last dose of study intervention.]
Acetaminophen PK parameters: Area under the plasma concentration (AUC) [Day 1 pre-dose through approximately 11 Weeks after last dose of study intervention.]
Acetaminophen PK parameters: Time to Maximum concentration (Tmax) [Day 1 pre-dose through approximately 11 Weeks after last dose of study intervention.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.